Tan DF - Search Results

1

MCM2--a promising marker for premalignant lesions of the lung: a cohort study.

Tan DF, Huberman JA, Hyland A, Loewen GM, Brooks JS, Beck AF, Todorov IT, Bepler G. Tan DF, et al. BMC Cancer. 2001;1:6. doi: 10.1186/1471-2407-1-6. Epub 2001 Jun 25. BMC Cancer. 2001. PMID: 11472637 Free PMC article.

2

Transformation of human bronchial epithelial cells alters responsiveness to inflammatory cytokines.

Loewen GM, Tracy E, Blanchard F, Tan D, Yu J, Raza S, Matsui S, Baumann H. Loewen GM, et al. BMC Cancer. 2005 Nov 4;5:145. doi: 10.1186/1471-2407-5-145. BMC Cancer. 2005. PMID: 16271139 Free PMC article.

3

Prognostic significance of MCM2, Ki-67 and gelsolin in non-small cell lung cancer.

Yang J, Ramnath N, Moysich KB, Asch HL, Swede H, Alrawi SJ, Huberman J, Geradts J, Brooks JS, Tan D. Yang J, et al. BMC Cancer. 2006 Aug 1;6:203. doi: 10.1186/1471-2407-6-203. BMC Cancer. 2006. PMID: 16882345 Free PMC article.

4

MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.

Ramnath N, Hernandez FJ, Tan DF, Huberman JA, Natarajan N, Beck AF, Hyland A, Todorov IT, Brooks JS, Bepler G. Ramnath N, et al. Among authors: tan df. J Clin Oncol. 2001 Nov 15;19(22):4259-66. doi: 10.1200/JCO.2001.19.22.4259. J Clin Oncol. 2001. PMID: 11709570

5

Prognostic significance of expression of p53 oncoprotein in primary (stage I-IIIa) non-small cell lung cancer.

Tan DF, Li Q, Rammath N, Beck A, Wiseman S, Anderson T, al-Salameh A, Brooks J, Bepler G. Tan DF, et al. Anticancer Res. 2003 Mar-Apr;23(2C):1665-72. Anticancer Res. 2003. PMID: 12820438

6

Thyroid transcription factor-1 expression prevalence and its clinical implications in non-small cell lung cancer: a high-throughput tissue microarray and immunohistochemistry study.

Tan D, Li Q, Deeb G, Ramnath N, Slocum HK, Brooks J, Cheney R, Wiseman S, Anderson T, Loewen G. Tan D, et al. Hum Pathol. 2003 Jun;34(6):597-604. doi: 10.1016/s0046-8177(03)00180-1. Hum Pathol. 2003. PMID: 12827614

7

Loss of cables protein expression in human non-small cell lung cancer: a tissue microarray study.

Tan D, Kirley S, Li Q, Ramnath N, Slocum HK, Brooks JS, Wu CL, Zukerberg LR. Tan D, et al. Hum Pathol. 2003 Feb;34(2):143-9. doi: 10.1053/hupa.2003.26. Hum Pathol. 2003. PMID: 12612882

8

HER-2/neu protein expression and gene alteration in stage I-IIIA non-small-cell lung cancer: a study of 140 cases using a combination of high throughput tissue microarray, immunohistochemistry, and fluorescent in situ hybridization.

Tan D, Deeb G, Wang J, Slocum HK, Winston J, Wiseman S, Beck A, Sait S, Anderson T, Nwogu C, Ramnath N, Loewen G. Tan D, et al. Diagn Mol Pathol. 2003 Dec;12(4):201-11. doi: 10.1097/00019606-200312000-00004. Diagn Mol Pathol. 2003. PMID: 14639106

9

Upregulation of the tissue inhibitor of metalloproteinase-1 protein is associated with progression of human non-small-cell lung cancer.

Aljada IS, Ramnath N, Donohue K, Harvey S, Brooks JJ, Wiseman SM, Khoury T, Loewen G, Slocum HK, Anderson TM, Bepler G, Tan D. Aljada IS, et al. J Clin Oncol. 2004 Aug 15;22(16):3218-29. doi: 10.1200/JCO.2004.02.110. Epub 2004 Jul 12. J Clin Oncol. 2004. PMID: 15249585

10

Prognostic significance of gelsolin expression level and variability in non-small cell lung cancer.

Yang J, Tan D, Asch HL, Swede H, Bepler G, Geradts J, Moysich KB. Yang J, et al. Lung Cancer. 2004 Oct;46(1):29-42. doi: 10.1016/j.lungcan.2004.03.022. Lung Cancer. 2004. PMID: 15364130

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters